RxDoctor Payments Data

Katherine Egan, MD

Plastic and Reconstructive Surgery · Indianapolis, INNPI 1790205706

Payments from drug & device makers

What this record shows

The money is spread across several categories — other (54.9%), food and beverage and education — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Integra Lifesciences Corporation at 55.6% of the total. 2025 is the largest year on record at $3,022, 5.2 times the $581 reported in 2023.

$4,751in general payments, 2019–2025

Across 39 payments — averaging $121.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$3K
  • Axogen$433
  • Smith+Nephew$292
  • Acumed LLC$222
  • Kerecis Limited$177
  • Johnson & Johnson$176
  • plus $812 from 9 others

What the payments were for

  • Travel & lodging$701%
  • Food & beverage$1,96541%
  • Education$1102%
  • Other$2,60655%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,751 in reported general payments places this provider in the 70th percentile of 47 plastic and reconstructive surgery providers in Indiana.

See all plastic and reconstructive surgery providers in Indiana

Medicare billing

Part B allowed, 2024
$3,886
Medicare patients
12
Services billed
28

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl25$82

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →